These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33248268)

  • 1. Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides.
    Grossen P; Portmann M; Koller E; Duschmalé M; Minz T; Sewing S; Pandya NJ; van Geijtenbeek SK; Ducret A; Kusznir EA; Huber S; Berrera M; Lauer ME; Ringler P; Nordbo B; Jensen ML; Sladojevich F; Jagasia R; Alex R; Gamboni R; Keller M
    Eur J Pharm Biopharm; 2021 Jan; 158():198-210. PubMed ID: 33248268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting murine alveolar macrophages by the intratracheal administration of locked nucleic acid containing antisense oligonucleotides.
    Uemura Y; Kobayashi K
    Drug Deliv; 2019 Dec; 26(1):803-811. PubMed ID: 31385541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.
    Moschos SA; Frick M; Taylor B; Turnpenny P; Graves H; Spink KG; Brady K; Lamb D; Collins D; Rockel TD; Weber M; Lazari O; Perez-Tosar L; Fancy SA; Lapthorn C; Green MX; Evans S; Selby M; Jones G; Jones L; Kearney S; Mechiche H; Gikunju D; Subramanian R; Uhlmann E; Jurk M; Vollmer J; Ciaramella G; Yeadon M
    Mol Ther; 2011 Dec; 19(12):2163-8. PubMed ID: 21971426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung.
    Uemura Y; Hagiwara K; Kobayashi K
    PLoS One; 2017; 12(11):e0187286. PubMed ID: 29107995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative fluorescence imaging determines the absolute number of locked nucleic acid oligonucleotides needed for suppression of target gene expression.
    Buntz A; Killian T; Schmid D; Seul H; Brinkmann U; Ravn J; Lindholm M; Knoetgen H; Haucke V; Mundigl O
    Nucleic Acids Res; 2019 Jan; 47(2):953-969. PubMed ID: 30462278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
    Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
    Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
    J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats.
    Romero-Palomo F; Festag M; Lenz B; Schadt S; Brink A; Kipar A; Steinhuber B; Husser C; Koller E; Sewing S; Tessier Y; Dzygiel P; Fischer G; Winter M; Hetzel U; Mihatsch MJ; Braendli-Baiocco A
    Toxicol Pathol; 2021 Aug; 49(6):1174-1192. PubMed ID: 34060347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals.
    Swayze EE; Siwkowski AM; Wancewicz EV; Migawa MT; Wyrzykiewicz TK; Hung G; Monia BP; Bennett CF
    Nucleic Acids Res; 2007; 35(2):687-700. PubMed ID: 17182632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo.
    Ma Y; Zhao W; Li Y; Pan Y; Wang S; Zhu Y; Kong L; Guan Z; Wang J; Zhang L; Yang Z
    Biomaterials; 2019 Mar; 197():182-193. PubMed ID: 30660994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides.
    Nikan M; Tanowitz M; Dwyer CA; Jackson M; Gaus HJ; Swayze EE; Rigo F; Seth PP; Prakash TP
    J Med Chem; 2020 Aug; 63(15):8471-8484. PubMed ID: 32677436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis.
    Samuel M; Fonseka P; Sanwlani R; Gangoda L; Chee SH; Keerthikumar S; Spurling A; Chitti SV; Zanker D; Ang CS; Atukorala I; Kang T; Shahi S; Marzan AL; Nedeva C; Vennin C; Lucas MC; Cheng L; Herrmann D; Pathan M; Chisanga D; Warren SC; Zhao K; Abraham N; Anand S; Boukouris S; Adda CG; Jiang L; Shekhar TM; Baschuk N; Hawkins CJ; Johnston AJ; Orian JM; Hoogenraad NJ; Poon IK; Hill AF; Jois M; Timpson P; Parker BS; Mathivanan S
    Nat Commun; 2021 Jun; 12(1):3950. PubMed ID: 34168137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.
    Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP
    Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site.
    Laxton C; Brady K; Moschos S; Turnpenny P; Rawal J; Pryde DC; Sidders B; Corbau R; Pickford C; Murray EJ
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3105-14. PubMed ID: 21502629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates.
    Straarup EM; Fisker N; Hedtjärn M; Lindholm MW; Rosenbohm C; Aarup V; Hansen HF; Ørum H; Hansen JB; Koch T
    Nucleic Acids Res; 2010 Nov; 38(20):7100-11. PubMed ID: 20615897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel dual lock method for down-regulation of genes, in which a target mRNA is captured at 2 independent positions by linked locked nucleic acid antisense oligonucleotides.
    Takata R; Makado G; Kitamura A; Watanabe H; Wada T
    RNA Biol; 2016; 13(3):279-89. PubMed ID: 26890856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Administration of Therapeutic Antisense Oligonucleotides.
    Statello L; Ali MM; Kanduri C
    Methods Mol Biol; 2021; 2254():273-282. PubMed ID: 33326082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models.
    Arntz OJ; Pieters BC; Oliveira MC; Broeren MG; Bennink MB; de Vries M; van Lent PL; Koenders MI; van den Berg WB; van der Kraan PM; van de Loo FA
    Mol Nutr Food Res; 2015 Sep; 59(9):1701-12. PubMed ID: 26047123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
    Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
    Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.